Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2026-01-17 @ 8:08 AM
Study NCT ID:
NCT01908192
Status:
TERMINATED
Last Update Posted:
2024-05-09
First Post:
2013-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Sponsor:
SyneuRx International (Taiwan) Corp
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06
Start Date Type:
None
Primary Completion Date:
2023-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-23
First Submit QC Date:
None
Study First Post Date:
2013-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-07
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL